Cardiology Update

JANUARY 24, 2024

Growing Global Burden of Cardiometabolic Risks: The 2023 World Obesity Atlas projects a significant rise in global overweight and obesity levels by 2035, leading to a surge in diabetes cases. The findings have significant implications for clinical and public health practice and research.

Cardiovascular Disease 119

Cardiovascular Disease Research Blood Pressure Public Health 119

DAIC

MARCH 8, 2024

mg or placebo to cardiovascular standard of care in adults with overweight and obesity with established CVD and without diabetes. director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA’s Center for Drug Evaluation and Research , in a statement issued by the FDA. 2 Wegovy 2.4 with placebo. mg and 36.4%

Obesity 111

Obesity Heart Disease Heart attacks Heart Attack 111

DAIC

MARCH 5, 2024

They adjusted for the participants' use of tobacco and other characteristics, including their age, sex, race, body mass index or BMI, obesity, diabetes, physical activity levels, and socioeconomic status. Goff , M.D., director of the NHLBI’s Division of Cardiovascular Sciences.

Heart Attack 98

Heart Attack Heart attacks Stroke Strokes 98